Table 3.
Outcome | IPAQ | Patients | Events | Median survival time in months (95% CI) | 6-month survival rate (95% CI) | 12-month survival rate (95% CI) | 24-month survival time (95% CI) | 36-month survival rate (95% CI) |
---|---|---|---|---|---|---|---|---|
PFS | low | 138 | 116 | 9.0 (6.3, 11.2) | 0.60 (0.52, 0.69) | 0.36 (0.29, 0.45) | 0.19 (0.13, 0.27) | 0.13 (0.08, 0.21) |
moderate | 995 | 838 | 7.6 (6.7, 8.1) | 0.57 (0.54, 0.60) | 0.35 (0.32, 0.38) | 0.22 (0.19, 0.24) | 0.14 (0.12, 0.17) | |
high | 137 | 124 | 7.2 (5.5, 9.3) | 0.54 (0.46, 0.63) | 0.29 (0.23, 0.38) | 0.16 (0.11, 0.24) | 0.11 (0.06, 0.17) | |
OS | low | 138 | 84 | 27.1 (20.4, 35.6) | 0.89 (0.84, 0.95) | 0.73 (0.65, 0.81) | 0.52 (0.44, 0.62) | 0.39 (0.31, 0.49) |
moderate | 995 | 597 | 27.7 (24.6, 30.3) | 0.90 (0.89, 0.92) | 0.76 (0.73, 0.78) | 0.54 (0.51, 0.57) | 0.41 (0.38, 0.44) | |
high | 137 | 74 | 33.5 (25.7, 40.0) | 0.93 (0.88, 0.97) | 0.83 (0.76, 0.90) | 0.62 (0.54, 0.71) | 0.46 (0.38, 0.56) |
PFS Progression free survival, OS Overall survival, IPAQ International Physical Activity Questionnaire, CI Confidence interval